0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmerging Market Insights, Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-0E6468
Home | Market Reports | Health | Nursing
Global Pharmerging Market Insights Forecast to 2028

Global Pharmerging Market Insights, Forecast to 2028

Code: QYRE-Auto-0E6468
Report
February 2022
Pages:128
QYResearch
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Pharmerging Market

The global Pharmerging market size is projected to reach US$ 1640.1 million by 2028, from US$ 907.8 million in 2021, at a CAGR of 8.7% during 2022-2028.

Fully considering the economic change by this health crisis, Tier 1 accounting for % of the Pharmerging global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Lung Cancer segment is altered to an % CAGR throughout this forecast period.
China Pharmerging market size is valued at US$ million in 2021, while the North America and Europe Pharmerging are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Pharmerging landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmerging market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmerging market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmerging market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmerging market.
Global Pharmerging Scope and Market Size
Pharmerging market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pharmerging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Tier 1
Tier 2
Tier 3

Segment by Application

Lung Cancer
Breast Cancer
Chronic Myeloid Leukemia
Lymphomas
Other

BY COMPANY

Pfizer
Sanofi
GlaxoSmithKline
AstraZeneca
Novartis
Johnson & Johnson
F. Hoffmann-La Roche
Eli Lilly
Boehringer Ingelheim
Novo Nordisk
AbbVie
Sun Pharmaceutical
Teva Pharmaceutical Industries
Mitsubishi Tanabe Pharma
Bristol-Myers Squibb
Kyowa Hakko Kirin
CSL Behring
Takeda
Amgen
Bayer
Biogen
Eisai
Daiichi Sankyo
Dainippon Sumitomo Pharma

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmerging Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tier 1
1.2.3 Tier 2
1.2.4 Tier 3
1.3 Market by Application
1.3.1 Global Pharmerging Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Chronic Myeloid Leukemia
1.3.5 Lymphomas
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmerging Market Perspective (2017-2028)
2.2 Pharmerging Growth Trends by Region
2.2.1 Pharmerging Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmerging Historic Market Size by Region (2017-2022)
2.2.3 Pharmerging Forecasted Market Size by Region (2023-2028)
2.3 Pharmerging Market Dynamics
2.3.1 Pharmerging Industry Trends
2.3.2 Pharmerging Market Drivers
2.3.3 Pharmerging Market Challenges
2.3.4 Pharmerging Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmerging Players by Revenue
3.1.1 Global Top Pharmerging Players by Revenue (2017-2022)
3.1.2 Global Pharmerging Revenue Market Share by Players (2017-2022)
3.2 Global Pharmerging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmerging Revenue
3.4 Global Pharmerging Market Concentration Ratio
3.4.1 Global Pharmerging Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmerging Revenue in 2021
3.5 Pharmerging Key Players Head office and Area Served
3.6 Key Players Pharmerging Product Solution and Service
3.7 Date of Enter into Pharmerging Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmerging Breakdown Data by Type
4.1 Global Pharmerging Historic Market Size by Type (2017-2022)
4.2 Global Pharmerging Forecasted Market Size by Type (2023-2028)
5 Pharmerging Breakdown Data by Application
5.1 Global Pharmerging Historic Market Size by Application (2017-2022)
5.2 Global Pharmerging Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmerging Market Size (2017-2028)
6.2 North America Pharmerging Market Size by Type
6.2.1 North America Pharmerging Market Size by Type (2017-2022)
6.2.2 North America Pharmerging Market Size by Type (2023-2028)
6.2.3 North America Pharmerging Market Share by Type (2017-2028)
6.3 North America Pharmerging Market Size by Application
6.3.1 North America Pharmerging Market Size by Application (2017-2022)
6.3.2 North America Pharmerging Market Size by Application (2023-2028)
6.3.3 North America Pharmerging Market Share by Application (2017-2028)
6.4 North America Pharmerging Market Size by Country
6.4.1 North America Pharmerging Market Size by Country (2017-2022)
6.4.2 North America Pharmerging Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pharmerging Market Size (2017-2028)
7.2 Europe Pharmerging Market Size by Type
7.2.1 Europe Pharmerging Market Size by Type (2017-2022)
7.2.2 Europe Pharmerging Market Size by Type (2023-2028)
7.2.3 Europe Pharmerging Market Share by Type (2017-2028)
7.3 Europe Pharmerging Market Size by Application
7.3.1 Europe Pharmerging Market Size by Application (2017-2022)
7.3.2 Europe Pharmerging Market Size by Application (2023-2028)
7.3.3 Europe Pharmerging Market Share by Application (2017-2028)
7.4 Europe Pharmerging Market Size by Country
7.4.1 Europe Pharmerging Market Size by Country (2017-2022)
7.4.2 Europe Pharmerging Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmerging Market Size (2017-2028)
8.2 Asia-Pacific Pharmerging Market Size by Type
8.2.1 Asia-Pacific Pharmerging Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pharmerging Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pharmerging Market Share by Type (2017-2028)
8.3 Asia-Pacific Pharmerging Market Size by Application
8.3.1 Asia-Pacific Pharmerging Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pharmerging Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pharmerging Market Share by Application (2017-2028)
8.4 Asia-Pacific Pharmerging Market Size by Region
8.4.1 Asia-Pacific Pharmerging Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pharmerging Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmerging Market Size (2017-2028)
9.2 Latin America Pharmerging Market Size by Type
9.2.1 Latin America Pharmerging Market Size by Type (2017-2022)
9.2.2 Latin America Pharmerging Market Size by Type (2023-2028)
9.2.3 Latin America Pharmerging Market Share by Type (2017-2028)
9.3 Latin America Pharmerging Market Size by Application
9.3.1 Latin America Pharmerging Market Size by Application (2017-2022)
9.3.2 Latin America Pharmerging Market Size by Application (2023-2028)
9.3.3 Latin America Pharmerging Market Share by Application (2017-2028)
9.4 Latin America Pharmerging Market Size by Country
9.4.1 Latin America Pharmerging Market Size by Country (2017-2022)
9.4.2 Latin America Pharmerging Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmerging Market Size (2017-2028)
10.2 Middle East & Africa Pharmerging Market Size by Type
10.2.1 Middle East & Africa Pharmerging Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pharmerging Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pharmerging Market Share by Type (2017-2028)
10.3 Middle East & Africa Pharmerging Market Size by Application
10.3.1 Middle East & Africa Pharmerging Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pharmerging Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pharmerging Market Share by Application (2017-2028)
10.4 Middle East & Africa Pharmerging Market Size by Country
10.4.1 Middle East & Africa Pharmerging Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pharmerging Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pharmerging Introduction
11.1.4 Pfizer Revenue in Pharmerging Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Pharmerging Introduction
11.2.4 Sanofi Revenue in Pharmerging Business (2017-2022)
11.2.5 Sanofi Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Pharmerging Introduction
11.3.4 GlaxoSmithKline Revenue in Pharmerging Business (2017-2022)
11.3.5 GlaxoSmithKline Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Pharmerging Introduction
11.4.4 AstraZeneca Revenue in Pharmerging Business (2017-2022)
11.4.5 AstraZeneca Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Pharmerging Introduction
11.5.4 Novartis Revenue in Pharmerging Business (2017-2022)
11.5.5 Novartis Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Pharmerging Introduction
11.6.4 Johnson & Johnson Revenue in Pharmerging Business (2017-2022)
11.6.5 Johnson & Johnson Recent Developments
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Pharmerging Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Pharmerging Business (2017-2022)
11.7.5 F. Hoffmann-La Roche Recent Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Pharmerging Introduction
11.8.4 Eli Lilly Revenue in Pharmerging Business (2017-2022)
11.8.5 Eli Lilly Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Pharmerging Introduction
11.9.4 Boehringer Ingelheim Revenue in Pharmerging Business (2017-2022)
11.9.5 Boehringer Ingelheim Recent Developments
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Details
11.10.2 Novo Nordisk Business Overview
11.10.3 Novo Nordisk Pharmerging Introduction
11.10.4 Novo Nordisk Revenue in Pharmerging Business (2017-2022)
11.10.5 Novo Nordisk Recent Developments
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Pharmerging Introduction
11.11.4 AbbVie Revenue in Pharmerging Business (2017-2022)
11.11.5 AbbVie Recent Developments
11.12 Sun Pharmaceutical
11.12.1 Sun Pharmaceutical Company Details
11.12.2 Sun Pharmaceutical Business Overview
11.12.3 Sun Pharmaceutical Pharmerging Introduction
11.12.4 Sun Pharmaceutical Revenue in Pharmerging Business (2017-2022)
11.12.5 Sun Pharmaceutical Recent Developments
11.13 Teva Pharmaceutical Industries
11.13.1 Teva Pharmaceutical Industries Company Details
11.13.2 Teva Pharmaceutical Industries Business Overview
11.13.3 Teva Pharmaceutical Industries Pharmerging Introduction
11.13.4 Teva Pharmaceutical Industries Revenue in Pharmerging Business (2017-2022)
11.13.5 Teva Pharmaceutical Industries Recent Developments
11.14 Mitsubishi Tanabe Pharma
11.14.1 Mitsubishi Tanabe Pharma Company Details
11.14.2 Mitsubishi Tanabe Pharma Business Overview
11.14.3 Mitsubishi Tanabe Pharma Pharmerging Introduction
11.14.4 Mitsubishi Tanabe Pharma Revenue in Pharmerging Business (2017-2022)
11.14.5 Mitsubishi Tanabe Pharma Recent Developments
11.15 Bristol-Myers Squibb
11.15.1 Bristol-Myers Squibb Company Details
11.15.2 Bristol-Myers Squibb Business Overview
11.15.3 Bristol-Myers Squibb Pharmerging Introduction
11.15.4 Bristol-Myers Squibb Revenue in Pharmerging Business (2017-2022)
11.15.5 Bristol-Myers Squibb Recent Developments
11.16 Kyowa Hakko Kirin
11.16.1 Kyowa Hakko Kirin Company Details
11.16.2 Kyowa Hakko Kirin Business Overview
11.16.3 Kyowa Hakko Kirin Pharmerging Introduction
11.16.4 Kyowa Hakko Kirin Revenue in Pharmerging Business (2017-2022)
11.16.5 Kyowa Hakko Kirin Recent Developments
11.17 CSL Behring
11.17.1 CSL Behring Company Details
11.17.2 CSL Behring Business Overview
11.17.3 CSL Behring Pharmerging Introduction
11.17.4 CSL Behring Revenue in Pharmerging Business (2017-2022)
11.17.5 CSL Behring Recent Developments
11.18 Takeda
11.18.1 Takeda Company Details
11.18.2 Takeda Business Overview
11.18.3 Takeda Pharmerging Introduction
11.18.4 Takeda Revenue in Pharmerging Business (2017-2022)
11.18.5 Takeda Recent Developments
11.19 Amgen
11.19.1 Amgen Company Details
11.19.2 Amgen Business Overview
11.19.3 Amgen Pharmerging Introduction
11.19.4 Amgen Revenue in Pharmerging Business (2017-2022)
11.19.5 Amgen Recent Developments
11.20 Bayer
11.20.1 Bayer Company Details
11.20.2 Bayer Business Overview
11.20.3 Bayer Pharmerging Introduction
11.20.4 Bayer Revenue in Pharmerging Business (2017-2022)
11.20.5 Bayer Recent Developments
11.21 Biogen
11.21.1 Biogen Company Details
11.21.2 Biogen Business Overview
11.21.3 Biogen Pharmerging Introduction
11.21.4 Biogen Revenue in Pharmerging Business (2017-2022)
11.21.5 Biogen Recent Developments
11.22 Eisai
11.22.1 Eisai Company Details
11.22.2 Eisai Business Overview
11.22.3 Eisai Pharmerging Introduction
11.22.4 Eisai Revenue in Pharmerging Business (2017-2022)
11.22.5 Eisai Recent Developments
11.23 Daiichi Sankyo
11.23.1 Daiichi Sankyo Company Details
11.23.2 Daiichi Sankyo Business Overview
11.23.3 Daiichi Sankyo Pharmerging Introduction
11.23.4 Daiichi Sankyo Revenue in Pharmerging Business (2017-2022)
11.23.5 Daiichi Sankyo Recent Developments
11.24 Dainippon Sumitomo Pharma
11.24.1 Dainippon Sumitomo Pharma Company Details
11.24.2 Dainippon Sumitomo Pharma Business Overview
11.24.3 Dainippon Sumitomo Pharma Pharmerging Introduction
11.24.4 Dainippon Sumitomo Pharma Revenue in Pharmerging Business (2017-2022)
11.24.5 Dainippon Sumitomo Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Pharmerging Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Tier 1
    Table 3. Key Players of Tier 2
    Table 4. Key Players of Tier 3
    Table 5. Global Pharmerging Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Pharmerging Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Pharmerging Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Pharmerging Market Share by Region (2017-2022)
    Table 9. Global Pharmerging Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Pharmerging Market Share by Region (2023-2028)
    Table 11. Pharmerging Market Trends
    Table 12. Pharmerging Market Drivers
    Table 13. Pharmerging Market Challenges
    Table 14. Pharmerging Market Restraints
    Table 15. Global Pharmerging Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Pharmerging Revenue Share by Players (2017-2022)
    Table 17. Global Top Pharmerging by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmerging as of 2021)
    Table 18. Ranking of Global Top Pharmerging Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Pharmerging Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Pharmerging Product Solution and Service
    Table 22. Date of Enter into Pharmerging Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Pharmerging Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Pharmerging Revenue Market Share by Type (2017-2022)
    Table 26. Global Pharmerging Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Pharmerging Revenue Market Share by Type (2023-2028)
    Table 28. Global Pharmerging Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Pharmerging Revenue Share by Application (2017-2022)
    Table 30. Global Pharmerging Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Pharmerging Revenue Share by Application (2023-2028)
    Table 32. North America Pharmerging Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Pharmerging Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Pharmerging Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Pharmerging Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Pharmerging Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Pharmerging Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Pharmerging Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Pharmerging Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Pharmerging Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Pharmerging Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Pharmerging Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Pharmerging Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Pharmerging Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Pharmerging Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Pharmerging Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Pharmerging Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Pharmerging Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Pharmerging Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Pharmerging Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Pharmerging Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Pharmerging Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Pharmerging Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Pharmerging Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Pharmerging Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Pharmerging Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Pharmerging Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Pharmerging Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Pharmerging Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Pharmerging Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Pharmerging Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Pfizer Company Details
    Table 63. Pfizer Business Overview
    Table 64. Pfizer Pharmerging Product
    Table 65. Pfizer Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 66. Pfizer Recent Developments
    Table 67. Sanofi Company Details
    Table 68. Sanofi Business Overview
    Table 69. Sanofi Pharmerging Product
    Table 70. Sanofi Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 71. Sanofi Recent Developments
    Table 72. GlaxoSmithKline Company Details
    Table 73. GlaxoSmithKline Business Overview
    Table 74. GlaxoSmithKline Pharmerging Product
    Table 75. GlaxoSmithKline Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 76. GlaxoSmithKline Recent Developments
    Table 77. AstraZeneca Company Details
    Table 78. AstraZeneca Business Overview
    Table 79. AstraZeneca Pharmerging Product
    Table 80. AstraZeneca Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 81. AstraZeneca Recent Developments
    Table 82. Novartis Company Details
    Table 83. Novartis Business Overview
    Table 84. Novartis Pharmerging Product
    Table 85. Novartis Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 86. Novartis Recent Developments
    Table 87. Johnson & Johnson Company Details
    Table 88. Johnson & Johnson Business Overview
    Table 89. Johnson & Johnson Pharmerging Product
    Table 90. Johnson & Johnson Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 91. Johnson & Johnson Recent Developments
    Table 92. F. Hoffmann-La Roche Company Details
    Table 93. F. Hoffmann-La Roche Business Overview
    Table 94. F. Hoffmann-La Roche Pharmerging Product
    Table 95. F. Hoffmann-La Roche Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 96. F. Hoffmann-La Roche Recent Developments
    Table 97. Eli Lilly Company Details
    Table 98. Eli Lilly Business Overview
    Table 99. Eli Lilly Pharmerging Product
    Table 100. Eli Lilly Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 101. Eli Lilly Recent Developments
    Table 102. Boehringer Ingelheim Company Details
    Table 103. Boehringer Ingelheim Business Overview
    Table 104. Boehringer Ingelheim Pharmerging Product
    Table 105. Boehringer Ingelheim Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 106. Boehringer Ingelheim Recent Developments
    Table 107. Novo Nordisk Company Details
    Table 108. Novo Nordisk Business Overview
    Table 109. Novo Nordisk Pharmerging Product
    Table 110. Novo Nordisk Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 111. Novo Nordisk Recent Developments
    Table 112. AbbVie Company Details
    Table 113. AbbVie Business Overview
    Table 114. AbbVie Pharmerging Product
    Table 115. AbbVie Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 116. AbbVie Recent Developments
    Table 117. Sun Pharmaceutical Company Details
    Table 118. Sun Pharmaceutical Business Overview
    Table 119. Sun Pharmaceutical Pharmerging Product
    Table 120. Sun Pharmaceutical Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 121. Sun Pharmaceutical Recent Developments
    Table 122. Teva Pharmaceutical Industries Company Details
    Table 123. Teva Pharmaceutical Industries Business Overview
    Table 124. Teva Pharmaceutical Industries Pharmerging Product
    Table 125. Teva Pharmaceutical Industries Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 126. Teva Pharmaceutical Industries Recent Developments
    Table 127. Mitsubishi Tanabe Pharma Company Details
    Table 128. Mitsubishi Tanabe Pharma Business Overview
    Table 129. Mitsubishi Tanabe Pharma Pharmerging Product
    Table 130. Mitsubishi Tanabe Pharma Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 131. Mitsubishi Tanabe Pharma Recent Developments
    Table 132. Bristol-Myers Squibb Company Details
    Table 133. Bristol-Myers Squibb Business Overview
    Table 134. Bristol-Myers Squibb Pharmerging Product
    Table 135. Bristol-Myers Squibb Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 136. Bristol-Myers Squibb Recent Developments
    Table 137. Kyowa Hakko Kirin Company Details
    Table 138. Kyowa Hakko Kirin Business Overview
    Table 139. Kyowa Hakko Kirin Pharmerging Product
    Table 140. Kyowa Hakko Kirin Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 141. Kyowa Hakko Kirin Recent Developments
    Table 142. CSL Behring Company Details
    Table 143. CSL Behring Business Overview
    Table 144. CSL Behring Pharmerging Product
    Table 145. CSL Behring Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 146. CSL Behring Recent Developments
    Table 147. Takeda Company Details
    Table 148. Takeda Business Overview
    Table 149. Takeda Pharmerging Product
    Table 150. Takeda Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 151. Takeda Recent Developments
    Table 152. Amgen Company Details
    Table 153. Amgen Business Overview
    Table 154. Amgen Pharmerging Product
    Table 155. Amgen Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 156. Amgen Recent Developments
    Table 157. Bayer Company Details
    Table 158. Bayer Business Overview
    Table 159. Bayer Pharmerging Product
    Table 160. Bayer Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 161. Bayer Recent Developments
    Table 162. Biogen Company Details
    Table 163. Biogen Business Overview
    Table 164. Biogen Pharmerging Product
    Table 165. Biogen Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 166. Biogen Recent Developments
    Table 167. Eisai Company Details
    Table 168. Eisai Business Overview
    Table 169. Eisai Pharmerging Product
    Table 170. Eisai Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 171. Eisai Recent Developments
    Table 172. Daiichi Sankyo Company Details
    Table 173. Daiichi Sankyo Business Overview
    Table 174. Daiichi Sankyo Pharmerging Product
    Table 175. Daiichi Sankyo Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 176. Daiichi Sankyo Recent Developments
    Table 177. Dainippon Sumitomo Pharma Company Details
    Table 178. Dainippon Sumitomo Pharma Business Overview
    Table 179. Dainippon Sumitomo Pharma Pharmerging Product
    Table 180. Dainippon Sumitomo Pharma Revenue in Pharmerging Business (2017-2022) & (US$ Million)
    Table 181. Dainippon Sumitomo Pharma Recent Developments
    Table 182. Research Programs/Design for This Report
    Table 183. Key Data Information from Secondary Sources
    Table 184. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmerging Market Share by Type: 2021 VS 2028
    Figure 2. Tier 1 Features
    Figure 3. Tier 2 Features
    Figure 4. Tier 3 Features
    Figure 5. Global Pharmerging Market Share by Application: 2021 VS 2028
    Figure 6. Lung Cancer Case Studies
    Figure 7. Breast Cancer Case Studies
    Figure 8. Chronic Myeloid Leukemia Case Studies
    Figure 9. Lymphomas Case Studies
    Figure 10. Other Case Studies
    Figure 11. Pharmerging Report Years Considered
    Figure 12. Global Pharmerging Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Pharmerging Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Pharmerging Market Share by Region: 2021 VS 2028
    Figure 15. Global Pharmerging Market Share by Players in 2021
    Figure 16. Global Top Pharmerging Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmerging as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Pharmerging Revenue in 2021
    Figure 18. North America Pharmerging Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Pharmerging Market Size Market Share by Type (2017-2028)
    Figure 20. North America Pharmerging Market Size Market Share by Application (2017-2028)
    Figure 21. North America Pharmerging Market Size Share by Country (2017-2028)
    Figure 22. United States Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Pharmerging Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Pharmerging Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Pharmerging Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Pharmerging Market Size Share by Country (2017-2028)
    Figure 28. Germany Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Pharmerging Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Pharmerging Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Pharmerging Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Pharmerging Market Size Share by Region (2017-2028)
    Figure 38. China Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Pharmerging Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Pharmerging Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Pharmerging Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Pharmerging Market Size Share by Country (2017-2028)
    Figure 48. Mexico Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Pharmerging Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Pharmerging Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Pharmerging Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Pharmerging Market Size Share by Country (2017-2028)
    Figure 54. Turkey Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Pharmerging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Pfizer Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 58. Sanofi Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 60. AstraZeneca Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 62. Johnson & Johnson Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 64. Eli Lilly Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 65. Boehringer Ingelheim Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 66. Novo Nordisk Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 67. AbbVie Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 68. Sun Pharmaceutical Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 69. Teva Pharmaceutical Industries Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 70. Mitsubishi Tanabe Pharma Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 72. Kyowa Hakko Kirin Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 73. CSL Behring Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 74. Takeda Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 75. Amgen Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 76. Bayer Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 77. Biogen Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 78. Eisai Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 79. Daiichi Sankyo Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 80. Dainippon Sumitomo Pharma Revenue Growth Rate in Pharmerging Business (2017-2022)
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Stem Cell Banking Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-8223
Thu Jan 26 00:00:00 UTC 2023

Add to Cart

Global Nitric Oxide Therapy System Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-13G13075
Thu Jan 26 00:00:00 UTC 2023

Add to Cart

Global Fractional Flow Reserve Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-39F2213
Thu Jan 26 00:00:00 UTC 2023

Add to Cart

Global Repeat Expansion Disorders Treatment Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-16N13089
Mon Jan 23 00:00:00 UTC 2023

Add to Cart